SCHEMBL15819328

SCHEMBL15819328

CCN(c1cc(Cl)cc(C(=O)OC)c1C)C1CCC(N(C)Cc2cccc(OC)c2)CC1

nearest known ligand 0.43

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ EZH2 Q15910 18/20 0.43
▸ THRB P10828 1/20 0.41
▸ KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15819327 1.00 EZH2 (0.43) EZH2THRBKMT2A
SCHEMBL15819725 0.92 EZH2 (0.44) EZH2THRBKMT2A
SCHEMBL15819727 0.92 EZH2 (0.44) EZH2THRBKMT2A
SCHEMBL16397700 0.90 EZH2 (0.45) EZH2
SCHEMBL16397699 0.90 EZH2 (0.45) EZH2
SCHEMBL16398375 0.84 OPRM1 (0.49) THRBKMT2A
SCHEMBL17288086 0.83 EZH2 (0.57) EZH2
SCHEMBL19391031 0.83 EZH2 (0.42) EZH2
SCHEMBL15839149 0.83 EZH2 (0.57) EZH2
SCHEMBL19390977 0.83 EZH2 (0.42) EZH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2935214-B1 1,4-PYRIDONE COMPOUNDS EPIZYME INC (US) 2019-02-20 — — EP disclosed
US-10150764-B2 Substituted benzene compounds Epizyme, Inc. (US) 2018-12-11 — — US disclosed
EP-3022184-B1 SUBSTITUTED BENZENE COMPOUNDS EPIZYME INC (US) 2017-09-27 — — EP disclosed
US-20160194316-A1 SUBSTITUTED BENZENE COMPOUNDS Epizyme, Inc. 2016-07-07 — — US disclosed
EP-3022184-A1 SUBSTITUTED BENZENE COMPOUNDS Epizyme, Inc. (US) 2016-05-25 — — EP disclosed
US-20150344427-A1 1,4-PYRIDONE COMPOUNDS Epizyme, Inc. (US) 2015-12-03 — — US disclosed
EP-2935214-A1 1,4-PYRIDONE COMPOUNDS Epizyme, Inc. (US) 2015-10-28 — — EP disclosed
WO-2015010049-A1 SUBSTITUTED BENZENE COMPOUNDS Epizyme, Inc. (US) 2015-01-22 — — WO disclosed
WO-2014100646-A1 1,4-PYRIDONE COMPOUNDS Epizyme, Inc. (US) 2014-06-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150344427-A1 1,4-PYRIDONE COMPOUNDS PDXK, PNPO, PLPBP EZH2 3465/4885THRB 4110/4885KMT2A 2663/4885
US-20160194316-A1 SUBSTITUTED BENZENE COMPOUNDS CYP1B1, TP53, VHL EZH2 2519/4885THRB 4020/4885KMT2A 1120/4885
US-10150764-B2 Substituted benzene compounds CYP1B1, TP53, VHL EZH2 2519/4885THRB 4020/4885KMT2A 1120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback